Literature DB >> 8169173

Update on lithium carbonate therapy in children and adolescents.

N Alessi1, M W Naylor, M Ghaziuddin, J K Zubieta.   

Abstract

The use of lithium to treat child and adolescent psychiatric disorders is becoming more common. Since the publication of the report of The Committee on Biological Aspects of Child Psychiatry of the American Academy of Child Psychiatry in 1978, a considerable body of literature has accumulated on the efficacy of lithium in treating adolescent bipolar disorders, childhood aggression, and behavioral disorders associated with mental retardation and developmental disorders. Efforts to understand lithium's mechanism(s) and refinements in psychiatric diagnosis have contributed to its growing use.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169173     DOI: 10.1097/00004583-199403000-00001

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  5 in total

Review 1.  Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner.

Authors:  N J Carrey; D M Wiggins; R P Milin
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

2.  Transient elevation of serum thyroid hormone levels following lithium discontinuation.

Authors:  C A Stratakis; G P Chrousos
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

Review 3.  Management options for bipolar disorder in children and adolescents.

Authors:  Arman Danielyan; Robert A Kowatch
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 4.  Current research in child and adolescent bipolar disorder.

Authors:  Christine A Demeter; Lisa D Townsend; Michael Wilson; Robert L Findling
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

5.  Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome.

Authors:  M K King; R S Jope
Journal:  Genes Brain Behav       Date:  2013-08-29       Impact factor: 3.449

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.